Skip to main content
Top
Published in: Hormones 2/2015

01-04-2015 | Letter to the Editor

Familial partial lipodystrophy type 3: a new mutation on the PPARG gene

Authors: Eva Lau, Davide Carvalho, Joana Oliveira, Susana Fernandes, Paula Freitas

Published in: Hormones | Issue 2/2015

Login to get access
Metadata
Title
Familial partial lipodystrophy type 3: a new mutation on the PPARG gene
Authors
Eva Lau
Davide Carvalho
Joana Oliveira
Susana Fernandes
Paula Freitas
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Hormones / Issue 2/2015
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1585

Other articles of this Issue 2/2015

Hormones 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine